Literature DB >> 21840929

Sex differences in HIV RNA level and CD4 cell percentage during childhood.

Theodore D Ruel1, Brian C Zanoni, Isaac Ssewanyana, Huyen Cao, Diane V Havlir, Moses Kamya, Jane Achan, Edwin D Charlebois, Margaret E Feeney.   

Abstract

BACKGROUND: HIV-infected women have lower HIV RNA levels and higher CD4-cell counts than do men. This observation has been attributed to the immunomodulatory effects of sex steroid hormones, such as estrogen and progesterone. Limited data exist regarding potential sex differences in HIV RNA level and CD4 parameters among prepubertal children with untreated HIV infection.
METHODS: We examined the relationship of sex to HIV RNA level and CD4 parameters among 670 perinatally HIV-infected, antiretroviral therapy-naive African children aged <18 years (median age, 4.8 years) using multivariate linear regression. In a subset of 188 children, we used longitudinal data to compare changes in HIV RNA levels and CD4 percentage over time. Levels of CD4 and CD8 T-cell activation (CD38+HLA-DR+) were also compared between boys and girls.
RESULTS: Female children had lower HIV RNA levels (P = .0004) and higher CD4 percentages (P < .0001), compared to male children. Multivariate linear regression demonstrated an independent association of sex with both HIV RNA level and CD4 percentages after controlling for other covariates. Multilevel mixed-effects linear regression analysis of longitudinal HIV RNA level and CD4 parameter data showed that sex differences persisted across all observed ages. Levels of T-cell activation did not differ between the sexes.
CONCLUSIONS: Significant sex differences in HIV RNA levels and CD4 parameters are present in HIV-infected children before the onset of puberty. These data suggest that intrinsic genetic differences between male and female individuals, unrelated to sex steroid hormone levels, influence HIV RNA level and CD4 parameters in HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840929      PMCID: PMC3160805          DOI: 10.1093/cid/cir484

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

Review 1.  The evolution of sex-biased genes and sex-biased gene expression.

Authors:  Hans Ellegren; John Parsch
Journal:  Nat Rev Genet       Date:  2007-08-07       Impact factor: 53.242

Review 2.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

3.  Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV.

Authors:  Marc Foca; Jack Moye; Clara Chu; Yvonne Matthews; Ken Rich; Ed Handelsman; Katherine Luzuriaga; Mary Paul; Clemente Diaz
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

Authors:  T R Sterling; D Vlahov; J Astemborski; D R Hoover; J B Margolick; T C Quinn
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  TLR7 ligands induce higher IFN-alpha production in females.

Authors:  Beate Berghöfer; Ture Frommer; Gabriela Haley; Ludger Fink; Gregor Bein; Holger Hackstein
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

6.  Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys?

Authors: 
Journal:  AIDS       Date:  2002-01-04       Impact factor: 4.177

7.  Association of race and gender with HIV-1 RNA levels and immunologic progression.

Authors:  K Anastos; S J Gange; B Lau; B Weiser; R Detels; J V Giorgi; J B Margolick; M Cohen; J Phair; S Melnick; C R Rinaldo; A Kovacs; A Levine; S Landesman; M Young; A Muñoz; R M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

8.  Estrogen regulates CCR gene expression and function in T lymphocytes.

Authors:  RuRan Mo; Jun Chen; Annabelle Grolleau-Julius; Hedwig S Murphy; Bruce C Richardson; Raymond L Yung
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.

Authors:  John R Ticehurst; Fayez M Hamzeh; David L Thomas
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.

Authors:  Brian C Zanoni; Thuli Phungula; Holly M Zanoni; Holly France; Margaret E Feeney
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

View more
  25 in total

Review 1.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

2.  Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial.

Authors:  Thanyawee Puthanakit; Vonthanak Saphonn; Jintanat Ananworanich; Pope Kosalaraksa; Rawiwan Hansudewechakul; Ung Vibol; Stephen J Kerr; Suparat Kanjanavanit; Chaiwat Ngampiyaskul; Jurai Wongsawat; Wicharn Luesomboon; Nicole Ngo-Giang-Huong; Kea Chettra; Theshinee Cheunyam; Tulathip Suwarnlerk; Sasiwimol Ubolyam; William T Shearer; Robert Paul; Lynne M Mofenson; Lawrence Fox; Matthew G Law; David A Cooper; Praphan Phanuphak; Mean Chhi Vun; Kiat Ruxrungtham
Journal:  Lancet Infect Dis       Date:  2012-10-09       Impact factor: 25.071

3.  Sonographic evaluation of kidney echogenicity and morphology among HIV sero-positive adults at Lagos University Teaching Hospital.

Authors:  Cletus Uche Eze; Charles Ugwoke Eze; Adekunle Adeyomoye
Journal:  J Ultrasound       Date:  2018-01-05

4.  Sex differences in cytokine profiles during suppressive antiretroviral therapy.

Authors:  Christophe Vanpouille; Alan Wells; Timothy Wilkin; Jyoti S Mathad; Sheldon Morris; Leonid Margolis; Sara Gianella
Journal:  AIDS       Date:  2022-05-25       Impact factor: 4.632

5.  Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.

Authors:  Mhairi Maskew; Alana T Brennan; Daniel Westreich; Lynne McNamara; A Patrick MacPhail; Matthew P Fox
Journal:  J Womens Health (Larchmt)       Date:  2013-01-25       Impact factor: 2.681

6.  Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Authors:  Naomi Swanta; Subhash Aryal; Vicki Nejtek; Sangeeta Shenoy; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Neurovirol       Date:  2020-03-19       Impact factor: 2.643

7.  Poor retention and care-related sex disparities among youth living with HIV in rural Mozambique.

Authors:  Aima A Ahonkhai; Muktar H Aliyu; Carolyn M Audet; Magdalena Bravo; Melynda Simmons; Gael Claquin; Peter Memiah; Anibal N Fernando; James G Carlucci; Bryan E Shepherd; Sara Van Rompaey; Zhihong Yu; Wu Gong; Sten H Vermund; C William Wester
Journal:  PLoS One       Date:  2021-05-21       Impact factor: 3.752

8.  Virologic Response to Very Early HIV Treatment in Neonates.

Authors:  Stephanie Shiau; Renate Strehlau; Yanhan Shen; Yun He; Faeezah Patel; Megan Burke; Elaine J Abrams; Caroline T Tiemessen; Shuang Wang; Louise Kuhn
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

9.  Pediatric response to second-line antiretroviral therapy in South Africa.

Authors:  Brian C Zanoni; Henry Sunpath; Margaret E Feeney
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

10.  Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.

Authors:  Masahiko Mori; Emily Adland; Paolo Paioni; Alice Swordy; Luisa Mori; Leana Laker; Maximilian Muenchhoff; Philippa C Matthews; Gareth Tudor-Williams; Nora Lavandier; Anriette van Zyl; Jacob Hurst; Bruce D Walker; Thumbi Ndung'u; Andrew Prendergast; Philip Goulder; Pieter Jooste
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.